Eugénia Cruz
Institute of Business & Medical Careers
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by Eugénia Cruz.
BMC Medical Genetics | 2006
Eugénia Cruz; Jorge Vieira; Susana Almeida; Rosa Lacerda; Andrea Gartner; Carla Cardoso; Helena Alves; Graça Porto
BackgroundIt has been recently demonstrated that CD8+ T-lymphocyte numbers are genetically transmitted in association with the MHC class I region. The present study was designed with the objective of narrowing the region associated with the setting of CD8+ T-lymphocyte numbers in a population of C282Y homozygous hemochromatosis subjects, in whom a high prevalence of abnormally low CD8+ T-lymphocyte counts has been described.MethodsThe study includes 43 C282Y homozygous subjects fully characterized both phenotypically and genotypically. Clinical characterization includes measurements of iron parameters at diagnosis (transferrin saturation and serum ferritin), total body iron stores and T-cell immunophenotyping determined by flow cytometry. Genetic characterization includes HLA class I alleles (A, B and C) and four additional microsatellite markers (D6S265, D6S2222, D6S105 and D6S2239) spanning 5 Megabases in the 6p21.3 region.ResultsEighty-two extended C282Y carrying haplotypes were defined. Single-locus analysis revealed that the HLA-A region was associated with CD8+ T-cell numbers. Multivariate analysis showed that the combinations of the most common HLA-A alleles (HLA-A*03, -A*02 and -A*01) were associated with significantly lower numbers of CD8+ T-lymphocytes (0.30 ± 0.14 × 106/ml), in comparison with subjects carrying only one copy of those alleles (0.46 ± 0.19 × 106/ml) and subjects without any copy of those alleles (0.79 ± 0.15 × 106/ml;p = 0.0001). No differences were observed in CD8+ T-cell counts among control subjects carrying the same combinations of HLA-A alleles (0.47 ± 0.14; 0.45 ± 0.21 and 0.41 ± 0.17 × 106/ml, respectively), therefore not supporting a direct effect of HLA specificity but rather an indirect association with a locus close to HLA-A. Multivariate analysis showed that the combination of the most common HLA-A alleles also have an impact on the clinical expression of HH in terms of iron stores, in males(p = 0.0009).ConclusionThe present study provides evidence supporting an inextricable link between extended HLA haplotypes, CD8+ T-lymphocyte numbers and severity of iron overload in hereditary hemochromatosis(HH). It gives additional information to better define a candidate region involved in the regulation of CD8+ T-lymphocyte numbers. A new evolutionary hypothesis concerning the inheritance of the phenotype of low CD8+ T-lymphocyte numbers associated with particular ancestral HLA haplotypes carrying the C282Y mutation and its implication on the clinical heterogeneity of HH is discussed.
European Journal of Haematology | 2001
Graça Porto; Carla Cardoso; Victor R. Gordeuk; Eugénia Cruz; José Fraga; Jorge Areias; José Carlos Oliveira; Fernanda Bravo; Innocent T. Gangaidzo; Macphail Ap; Zvenyika A. R. Gomo; Victor M. Moyo; Graça Melo; Cidália Silva; Benvindo Justiça; Maria de Sousa
Abstract: To identify a new marker of expression of disease, independent of HFE genotype in patients with hereditary haemochromatosis (HHC), the total peripheral blood lymphocyte counts were analysed according to iron status in two groups of subjects with HFE mutations. The groups consisted of 38 homozygotes for C282Y, and 107 heterozygotes for the C282Y or compound heterozygotes for C282Y and H63D. For control purposes, total lymphocyte counts and iron status were also examined in 20 index patients with African dietary iron overload, a condition not associated with HFE mutations, and in 144 members of their families and communities. Mean lymphocyte numbers were lower in C282Y homozygous HHC index subjects with cirrhosis and higher iron stores than in those without cirrhosis and with lower iron burdens [(1.65 ± 0.43) × 106/mL vs. (2.27 ± 0.49) × 106/mL; p = 0.008]. Similarly, mean lymphocyte counts were significantly lower in C282Y heterozygotes and C282Y/H63D compound heterozygotes with iron overload and increased serum ferritin concentrations compared to those with normal serum ferritin concentrations (p < 0.05). Statistically significant negative correlations were found, in males, between lymphocyte counts and the total body iron stores, either in C282Y homozygous HHC patients (p = 0.031 in a multiple regression model dependent on age) and in C282Y heterozygotes or C282Y/H63D compound heterozygotes with iron overload (p = 0.029 in a simple linear model). In contrast, lymphocyte counts increased with increasing serum ferritin concentrations among the index subjects with African iron overload (r = 0.324, not statistically significant) and among the members of their families and communities (r = 0.170, p = 0.042). These results suggest that a lower peripheral blood lymphocyte count is associated with a greater degree of iron loading in HFE haemochromatosis but not in African iron overload, and they support the notion that the lymphocyte count may serve as a marker of a non‐HFE gene that influences the clinical expression of HFE haemochromatosis.
Immunogenetics | 2002
Carla Cardoso; Helena Alves; Mónica Mascarenhas; Ricardo Gonçalves; Pedro Oliveira; Pedro Rodrigues; Eugénia Cruz; Maria de Sousa; Graça Porto
The major histocompatibility complex (MHC) shows a remarkable conservation of particular HLA antigens and haplotypes in linkage disequilibrium in most human populations, suggesting the existence of a convergent evolution. A recent example of such conservation is the association of particular HLA haplotypes with the HFE mutations. With the objective of exploring the significance of that association, the present paper offers an analysis of the linkage disequilibrium between HLA alleles or haplotypes and the HFE mutations in a Portuguese population. Allele and haplotype associations between HLA and HFE mutations were first reviewed in a population of 43 hemochromatosis families. The results confirmed the linkage disequilibrium of the HLA haplotype HLA-A3-B7 and the HLA-A29 allele, respectively, with the HFE mutations C282Y and H63D. In order to extend the study of the linkage disequilibrium between H63D and the HLA-A29-containing haplotypes in a normal, random population, an additional sample of 398 haplotypes was analyzed. The results reveal significant linkage disequilibrium between the H63D mutation and all HLA-A29-containing haplotypes, favoring the hypothesis of a co-selection of H63D and the HLA-A29 allele itself. An insight into the biological significance of this association is given by the finding of significantly higher CD8+ T-lymphocyte counts in subjects simultaneously carrying the H63D mutation and the HLA-A29 allele.
Clinical Endocrinology | 2004
Graça Porto; Eugénia Cruz; Helena Pessegueiro Miranda; Beatriz Porto; José Carlos Vasconcelos; Rosa Lacerda; Antonella Roetto; Filomena Daraio; Conceição Bacelar
This paper describes a rare case of Turners syndrome associated with Juvenile Haemochromatosis and severe lymphopenia, followed‐up for a period of 5 years. Because of the indication for treatment with growth hormone (GH), this case was observed as a model to analyse the effects of GH on growth, iron mobilization and lymphocyte reconstitution. For this purpose, a serial study of the T lymphocyte subpopulations CD4+, CD8+, CD8+ CD28+ and CD8+ CD28‐ was performed by immunophenotyping during the follow‐up period. Besides the impact of both phlebotomy treatment and GH on the rapid growth and mobilization of 20·8 g of iron in 136 weeks, the most relevant observation was the finding of a significant expansion of CD8+ T lymphocytes expressing the costimulatory marker CD28 in the setting of the severe lymphopenia. These findings constitute new clinical evidence supporting the notion that the GH/IGF‐1 system has an important role on the maintenance of T cell homeostasis in vivo, and that GH may be regarded as a putative therapeutic agent in T lymphocyte reconstitution.
European Journal of Cancer Prevention | 2005
Rui Medeiros; Prazeres H; Daniela Pinto; Macedo-Pinto I; Lacerda M; C. Lopes; Eugénia Cruz
Blood Cells Molecules and Diseases | 2006
Eugénia Cruz; Graça Melo; Rosa Lacerda; Susana Almeida; Graça Porto
Biochemical and Biophysical Research Communications | 2006
Carla Cardoso; Hélder C. Araújo; Eugénia Cruz; Ana Afonso; Cláudia Mascarenhas; Susana Almeida; José Moutinho; Carlos Lopes; Rui Medeiros
Tissue Antigens | 2004
Eugénia Cruz; J. Vieira; Ricardo Gonçalves; Helena Alves; Susana Almeida; Pedro Rodrigues; Rosa Lacerda; Graça Porto
Alcoholism: Clinical and Experimental Research | 2000
Fernando A. Arosa; Graça Porto; Josh Manuel Cabeda; Rosa Lacerda; Dolores Resende; Eugénia Cruz; Carla Cardoso; Mafalda Fonseca; Carla Simões; Pedro Pereira Rodrigues; Fernanda Bravo; José Carlos Oliveira; Helena Alves; José Fraga; Benvindo Justiça; Maria de Sousa
Blood Cells Molecules and Diseases | 2005
M. Fatima Macedo; Eugénia Cruz; Rosa Lacerda; Graça Porto; Maria de Sousa